Over 200 scientists and researchers studying Tuberculosis (TB) have come together at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad for a four-day international workshop. Organized by the European Molecular Biology Organization (EMBO), the event focuses on understanding how the TB-causing bacteria, Mycobacterium tuberculosis, interacts with the human body.
The workshop, which runs until February 12, has attracted around 170 research scholars and postdoctoral fellows from India and abroad. They will exchange knowledge and discuss new findings on TB infections, antibiotic resistance, and potential treatment strategies.
Delivering the keynote address, Dr. Rajesh Gokhale, Secretary of the Department of Biotechnology, Government of India, spoke about how TB bacteria not only infect lung cells but also hide in other parts of the body, such as the liver. He shared research from his team showing how liver cells create a safe environment for the bacteria, making it harder for antibiotics to eliminate them. He also linked these findings to India’s mission to eradicate TB.
Throughout the workshop, scientists will discuss how Mycobacterium tuberculosis evolves to evade the immune system and antibiotics. Advanced tools like genomics are being used to study these mechanisms, with the aim of improving TB diagnosis and vaccine development.
“This is the first EMBO workshop on TB biology in India in five years. We hope it will provide a platform for researchers to tackle unanswered questions and find new ways to fight this disease,” said Dr. Vinay K. Nandicoori, Director of CSIR-CCMB and one of the organizers.
The event is jointly organized by Dr. Amit Singhal from A STAR Infectious Diseases Labs in Singapore, Dr. Dhiraj Kumar from the International Centre for Genetic Engineering and Biotechnology, New Delhi, and Dr. Priscille Brodin from Institut Pasteur de Lille, France. EMBO is the primary sponsor of the workshop, according to a statement from CCMB.




